William J. Link Phd - Aug 3, 2021 Form 4 Insider Report for RxSight, Inc. (RXST)

Role: Director, 10%+ Owner
Signature: /s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol: RXST
Transactions as of: Aug 3, 2021
Transactions value $: $500,000
Form type: 4
Date filed: 8/5/2021, 07:34 PM
Previous filing: Aug 2, 2021
Next filing: Oct 20, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXST	Common Stock	Conversion of derivative security	$0	+2.02M		$0.00	2.02M	Aug 3, 2021	See footnote	F1, F2
transaction	RXST	Common Stock	Purchase	$500K	+31.3K	+533.37%	$16.00	37.1K	Aug 3, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXST	Series H Preferred Stock	Conversion of derivative security	$0	-2.02M	-100%	$0.00^*	0	Aug 3, 2021	Common Stock	2.02M		See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
F2	Shares held by RxSight I, LLC. The Reporting Person is a managing member of RxSight I, LLC and may be deemed to share voting and investment power over the securities held by RxSight I, LLC. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.